Press releases | WebDisclosure

Basculer en Français

11332	Companies
251880	Keywords
181168	Articles
137679	Press releases

Home
Press releases

PRESS RELEASE

published on 07/24/2025 at 08:00, 1 year 3 months ago

vVARDIS’ Drill-Free Solution Curodont™ Has Treated Over One Million Teeth in 18 Months and Is the Fastest Growing Dental Care Product in Its Category
vVARDIS' Curodont™ drill-free solution has treated over one million teeth in 18 months, elevating caries management standards. Clinical experts praise it as a revolutionary advancement in dentistry

Innovation Dental Care VVARDIS Curodont™ Caries Management
PRESS RELEASE

published on 07/24/2025 at 08:00, 1 year 3 months ago

TRILOGIQ - Comptes consolidés annuels au 31 mars 2025
Trilogiq publie ses comptes consolidés annuels au 31 mars 2025, avec un chiffre d'affaires de 23.203 K€ et un excédent brut d'exploitation de 1.223 K€, marqués par une légère baisse et une optimisation des coûts

Chiffre D'affaires Baisse Comptes Consolidés Excédent Brut D'Exploitation TRILOGIQ
PRESS RELEASE

published on 07/24/2025 at 07:56, 1 year 3 months ago

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
AB Science receives approval from European countries to initiate Phase 3 study of masitinib in ALS following protocol validation by EMA and FDA

Phase 3 Study ALS AB Science Masitinib EMA
PRESS RELEASE

published on 07/24/2025 at 07:56, 1 year 3 months ago

AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l’étude confirmatoire de phase 3 avec le masitinib dans la SLA
AB Science a obtenu l'autorisation de plusieurs pays européens pour initier l'étude confirmatoire de phase 3 avec le masitinib dans la sclérose latérale amyotrophique. Protocole validé par l'EMA et autorisation de la FDA

AB Science Masitinib Sclérose Latérale Amyotrophique Étude Confirmatoire Autorisation Européenne
PRESS RELEASE

published on 07/24/2025 at 07:37, 1 year 3 months ago

Résultats du premier semestre 2025
PRESS RELEASE

published on 07/24/2025 at 07:30, 1 year 3 months ago

Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris
Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris. La société de biotechnologie se concentre sur le développement de traitements pour les maladies inflammatoires chroniques

Euronext Paris Biotechnologie Abivax Traitements Thérapeutiques Suspension Temporaire
PRESS RELEASE

published on 07/24/2025 at 07:30, 1 year 3 months ago

Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris
Abivax annonce la suspension temporaire du cours de ses actions ordinaires sur Euronext Paris. La suspension intervient dans le cadre de l'Offre d'American Depositary Shares

Euronext Paris Biotechnologie Abivax Offre Publique Suspension Temporaire
PRESS RELEASE

published on 07/24/2025 at 07:30, 1 year 3 months ago

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris due to public offering preparations

Euronext Paris Abivax Trading Halt Public Offering Clinical-stage Biotechnology
PRESS RELEASE

published on 07/24/2025 at 07:30, 1 year 3 months ago

Vossloh achieves high sales and EBIT growth in the second quarter of 2025
Vossloh reports high sales and EBIT growth in Q2 2025, with a 13.5% sales increase and 18.9% EBIT rise, affirming growth outlook for the year

Sales Growth Order Backlog Vossloh EBIT Growth Q2 2025
PRESS RELEASE

published on 07/24/2025 at 07:10, 1 year 3 months ago

AMAG Austria Metall AG: Broad set-up enabled solid half-year results 2025
AMAG Austria Metall AG reports solid half-year results for 2025 despite challenges like US tariffs and cost increases, with revenues growing by +11.1% to EUR 786.2 million

Revenues EBITDA Half-year Results AMAG Austria Metall AG US Tariffs

Accesswire

Published on 11/13/2026 at 09:00, 19 minutes ago

Touchstone Exploration Announces Third Quarter 2026 Results
Published on 11/13/2026 at 02:40, 6 hours 39 minutes ago

Jaguar Mining Reports Third Quarter 2026 Results with 67% Growth in Adjusted Net Income and 46% Higher Adjusted EBITDA
Published on 11/13/2026 at 02:10, 7 hours 9 minutes ago

Amarc to Participate in Consolidation of Aurora West Through Aurora Minerals LTD
Published on 11/12/2026 at 23:25, 9 hours 54 minutes ago

Renegade Gold Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 11/12/2026 at 23:05, 10 hours 14 minutes ago

Caldwell Reports Fourth Quarter and Full Year Fiscal 2026 Results; Increases Quarterly Dividend and Declares a Special Dividend

View all ACCESSWIRE

EQS Group

Published on 11/13/2026 at 09:01, 17 minutes ago

Original-Research: GFT Technologies SE (von NuWays AG): BUY
Published on 11/13/2026 at 09:01, 17 minutes ago

Original-Research: Multitude AG (von NuWays AG): BUY
Published on 11/13/2026 at 09:00, 18 minutes ago

Original-Research: tonies SE (von NuWays AG): BUY
Published on 11/13/2026 at 09:00, 18 minutes ago

Original-Research: MLP SE (von NuWays AG): BUY
Published on 11/13/2026 at 09:00, 18 minutes ago

Original-Research: Semperit AG Holding (von NuWays AG): BUY

Les Echos

Published on 11/13/2026 at 08:00, 1 hour 19 minutes ago

Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 10 hours 6 minutes ago

Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 23:12, 10 hours 6 minutes ago

Belgrano poursuit la mise en oeuvre de son projet d'OPRA
Published on 11/12/2026 at 23:00, 10 hours 19 minutes ago

Assemblée générale du 12 novembre 2026 : quorum non atteint - Convocation d’une seconde assemblée générale le 27 novembre 2026
Published on 11/12/2026 at 18:36, 14 hours 42 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026

View all LES ECHOS COMFI WIRE